Short answer
Core Laboratories Inc. /DE/ (CLB) filed an 8-K current report with the SEC on October 28, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), Item EX-99.1 (Exhibit EX-99.1). Third-quarter 2026 earnings release, providing the latest operating and financial update for Core Laboratories.
Core Laboratories Inc. /DE/ 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Third-quarter 2026 earnings release, providing the latest operating and financial update for Core Laboratories
- Full results and management commentary contained in the October 28, 2026 press-release exhibit
Item 7.01 · Regulation FD Disclosure
- Quarterly cash dividend maintained at $0.01 per share
- Shareholder record date: November 9, 2026
- Payment date: November 30, 2026
- Dividend provides near-term shareholder return, with no broader strategic announcement in the disclosure
Item EX-99.1 · Exhibit EX-99.1
- Q3 revenue $132.1M, up 6% sequentially but down 2% year-over-year, signaling recovery without full demand normalization
- Ex-items EPS $0.16, up 46% sequentially but down 27% year-over-year, with operating margin near 10%
- Reservoir Description revenue $84.3M, up 7% sequentially, while operating income rose 109% sequentially to $7.7M
- Free cash flow $1.7M, constrained by higher inventory and receivables, with net debt $93.4M and leverage below 1.50
- Q4 revenue guidance $128.5M-$134.5M and EPS $0.12-$0.20, reflecting Middle East delays and seasonal U.S. moderation
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Core Laboratories Inc. /DE/ 8-K filings
Get the next CLB 8-K as it lands
Follow CLB for push alerts, or ask the research agent what this filing means.